Redx Pharma (REDX)

Company name:Redx Pharma Plc
EPIC:REDXTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BSNB6S51
Market Segment:ASQ1Share Type:DE
WWW Address: 1P
 Price Price Change [%] Bid Offer Open High Low Volume
 7.00 0.0 [0.00] 6.50 7.50 7.00 7.00 7.00 -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 8.85 126.48 -0.06 -7.00 - - - 17.50 - 5.00

Redx Pharma Key Figures

(at previous day's close)
Market Cap.8.85m
Shares In Issue126.48m
Prev. Close7.00
PE Ratio- 
Dividend Yield-%
EPS - basic-7.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-13.58p
Return On Equity (ROE)-153.45%
Operating Margin-7,865.12%
PEG Factor- 
EPS Growth Rate-600.00%
Dividends PS Growth Rate-%
Net Debt-1.92m
Gross Gearing44.14%
Quick Assets9.71m
Net Working Capital5.76m
Intangibles / Fixed Assets68.89%
Turnover PS0.10p
Pre-Tax Profit PS-8.02p
Retained Profit PS-6.99p
Cash PS5.12p
Net Cash PS1.99p
Net Tangible Asset Value PS *4.22p
Net Asset Value PS4.56p
Spread1.00 (13.33%) 

Redx Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week8.006.50
4 weeks8.006.50
12 weeks9.506.50
1 year17.505.00

Share Price Chart (5 years)

Redx Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week7.25-0.25-3.456.500.197.00
4 weeks7.00--6.500.087.01
12 weeks8.75-1.75-20.006.500.097.46
26 weeks5.251.7533.335.000.1710.53
1 year7.25-0.25-3.455.000.119.55
3 years43.00-36.00-83.723.500.1614.29
5 years86.50-79.50-91.913.500.1327.25

Redx Pharma Key Management Ratios

Redx Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.47 
Tobin's Q Ratio (excl. intangibles)0.48 
Dividend Yield-%
Market-to-Book Ratio1.54 
Price-to-Pre-Tax Profit PS-0.87 
Price-to-Retained Profit PS-1.00 
Price-to-Cash Flow PS-0.52 
Price-to-Sales PS68.63 
Price-to-Net Tangible Asset Value PS1.66 
Price-to-Cash PS1.37 
Net Working Capital PS4.55 
Price Pct to Working Capital PS1.54%
Earnings Yield-%
Average PE23.13 
Years in average1 
PE to PE average-%

Redx Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio9.50%
Debt-to-Equity Ratio0.10 
Debt-to-Equity Ratio (excl. Intgbl)0.11 
Debt-to-Equity Market Value0.07 
Net Gearing-18.57%
Net Gearing (excl. Intangibles)-19.36%
Gross Gearing44.14%
Gross Gearing (excl. Intangibles)46.03%
Gearing Under 1 Year38.28%
Gearing Under 1 Year (excl. Intgbl)39.92%
(Liquidity Ratios)
Net Working Capital to Total Assets55.77%
Current Ratio2.46 
Quick Ratio (Acid Test)2.46 
Liquidity Ratio1.64 
Cash & Equiv/Current Assets66.68%
(Solvency Ratios)
Enterprise Value2.99m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.51 
Total Debt/Sales35.31 
Total Debt/Pre-Tax Profit-0.45 
Total Debt4.56m
Total Debt/Net Current Assets0.79%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-29.29%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)

Redx Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-159.30%
Return On Assets (ROA)-46.54%
Net Profit Margin-6,856.59%
Assets Turnover0.01 
Return On Equity (ROE)-153.45%
Return On Investment (ROI)-85.48%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-6,856.59%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.01 
Fixed Assets Turnover0.20 
Current Assets Turnover0.01 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales147.32 
Debt Collection Period9,146.22Days

Redx Pharma Dividends

Sorry No Data Available

Redx Pharma Fundamentals

 30 Sep 2015 (GBP)30 Sep 2016 (GBP)30 Sep 2017 (GBP)30 Sep 2018 (GBP)
pre tax profit-9.43--15.41-1.655.40%-10.15-m
attributable profit-8.83--15.52-1.535.01%-8.85-m
retained profit-8.18--15.52-1.535.01%-8.85-m
eps - basic (p)-14.10 -19.80 1.40 -7.00 
eps - diluted (p)-14.10 -19.80 1.40 -7.00 
dividends per share- - - - 

Redx Pharma Balance Sheet

 30 Sep 2015 (GBP)30 Sep 2016 (GBP)30 Sep 2017 (GBP)30 Sep 2018 (GBP)
 30 Sep 2015 (GBP)30 Sep 2016 (GBP)30 Sep 2017 (GBP)30 Sep 2018 (GBP)
fixed assets fixed assets0.352.57%0.535.67%0.220.80%0.191.85%m
intangibles intangibles0.312.25%0.313.29%0.431.55%0.424.10%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors3.6626.59%2.8029.75%3.2311.67%3.2331.34%m
cash & securities cash & securities9.4468.60%5.7661.29%23.8185.98%6.4762.71%m
creditors - short creditors - short4.0629.49%7.6881.69%13.3648.26%3.9538.28%m
creditors - long creditors - long2.0014.54%--%--%0.615.86%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves7.7055.98%1.7218.31%14.3351.74%5.7655.86%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Redx Pharma Cash Flow Statement

30 Sep 2015 (GBP)30 Sep 2016 (GBP)30 Sep 2017 (GBP)30 Sep 2018 (GBP)
Operating CF-6.54-12.5114.10-17.18m
Pre-Financing CF-6.90-12.9514.07-17.29m
Retained CF6.54-3.6818.05-17.34m

Redx Pharma Brokers

Broker infomation is not available for this class of stock.
Your Recent History
Redx Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191205 15:32:05